Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Noventra Pharma Selank 7.5 mg

R 1,100.00 R 1,090.00
Add to WishlistCompare

Noventra Pharma Selank 7.5 mg — Multi-Dose Pen

Product Description

Discover the science behind Selank with Noventra Pharma Selank 7.5 mg, presented in a 3 ml multi-dose pen format.

Selank is a synthetic heptapeptide derived from the structure of tuftsin. It has been investigated primarily in Russian research exploring anxiety-related pathways, stress responses, and aspects of neurological function.

Selank research has attracted interest because of its proposed interactions with neurotransmitter systems involved in emotional regulation. However, the available clinical evidence remains limited, and further independent, well-controlled studies are needed to establish its effects and safety.

Product Specifications

  • Brand: Noventra Pharma

  • Compound: Selank

  • Labelled strength: 7.5 mg

  • Format: Multi-dose pen

  • Pen volume stated on packaging: 3 ml

  • Pen counter: 300 clicks

  • Packaging: Includes 8 sterile, single-use injection needles, according to the label

  • Research category: Neurobiology, stress-response pathways and neurotransmitter research

Key Research Areas

1. Anxiety-related pathways

Small clinical studies conducted in Russia have investigated Selank in adults with anxiety-related disorders. Some reported improvements in anxiety-rating scores, although limitations in study design and independent replication mean the findings remain preliminary.

2. Stress-response mechanisms

Preclinical research has explored Selank's potential interactions with GABA-related signalling and other biochemical pathways involved in stress responses.

3. Neurotransmitter regulation

Laboratory research has examined possible effects on enzymes involved in the breakdown of enkephalins, naturally occurring peptides associated with pain regulation and other neurological processes.

4. Cognitive function

Some experimental studies have explored memory-related and cognitive outcomes. However, there is insufficient robust human evidence to establish that Selank improves focus, memory, mental clarity or cognitive performance in healthy adults.

What Does the Clinical Research Show?

Published human research includes small Russian studies examining Selank in people with anxiety-related conditions.

Reported findings include:

  • Changes in measured anxiety symptoms in some study participants.

  • Results suggesting possible anxiety-related effects comparable to an active comparator in a small study.

  • Preliminary observations concerning fatigue-related symptoms and neurological measures.

Key Features

Selank research product — Identified as Selank for laboratory and scientific research contexts.

7.5 mg labelled total content — Clearly stated product content, not a recommended dose or administration instruction.

Noventra Pharma brand — Listed under the Noventra Pharma product name.

Research-use-only designation — Not intended for human or veterinary use, self-administration, or therapeutic purposes.

Manufacturer-guided handling — Refer to the manufacturer's supplied documentation for product-specific storage and handling requirements.

Dosage & Usage

Standard

  • 250 mcg – once per day (10 clicks)
  • 350 mcg – once per day (14 clicks)

Advanced

  • 200 mcg – twice per day (8 clicks)
  • 250 mcg – twice per day (10 clicks)

FAQ's & Tips

What is Noventra Pharma Selank 7.5 mg?

It is a Selank product supplied under the Noventra Pharma brand, with a labelled total content of 7.5 mg.

Does 7.5 mg refer to a recommended dose?

No. The 7.5 mg figure refers to the labelled total content, not a dosing or administration recommendation.

Is this product intended for human or veterinary use?

This listing is for laboratory and scientific research only. It is not intended for human or veterinary use, self-administration, or the diagnosis, treatment, cure, or prevention of disease.

How should the product be stored and handled?

Follow the manufacturer's supplied documentation for product-specific storage conditions and handling requirements. Handling should be carried out by appropriately trained personnel in a suitable research setting.

Where can I confirm purity or testing information?

Refer to the manufacturer's batch-specific documentation or certificate of analysis, where available. The product name and labelled content alone do not confirm purity, sterility, or independent testing.

Research

Selank research literature

The links below open searches for published literature mentioning Selank. They are provided as research references, not as evidence of the safety, effectiveness, purity, or quality of the Noventra Pharma finished product.

Search Selank publications on PubMed

Search Selank full-text articles on PubMed Central

Explore Selank literature on Google Scholar

Evaluate each publication's study model, methods, limitations, and relevance independently. Research on a compound does not establish that this specific product has been clinically tested or approved for therapeutic use. These references do not provide dosing or self-administration guidance.

For laboratory and scientific research only. Not intended for human or veterinary use.

Reviews